Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats

Biological Psychiatry

Volumn 57, Issue 10, 2005, Pages 1138-1146

  Martinez, Vicente ^a   Parikh, Vinay ^a   Sarter, Martin ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acetylcholine; Amphetamine; Attention; Schizophrenia; Sensitization

Indexed keywords

AMPHETAMINE; PROTEIN FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION; BRAIN REGION; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FOREBRAIN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SCHIZOPHRENIA; SENSITIZATION; TASK PERFORMANCE; TISSUE SECTION;

EID: 18144418938     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.02.005     Document Type: Article

References (68)

1. A. Abi-Dargham, R. Gil, J. Krystal, R.M. Baldwin, J.P. Seibyl, M. Bowers Increased striatal dopamine transmission in schizophrenia Confirmation in a second cohort Am J Psychiatry 155 1998 761 767
2. N.C. Andreasen, S. Paradiso, D.S. O'Leary "Cognitive dysmetria" as an integrative theory of schizophrenia A dysfunction in cortical- subcortical-cerebellar circuitry? Schizophr Bull 24 1998 203 218
3. J.S. Andrews, S.G. Holtzman Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats Psychopharmacology (Berl) 94 1988 172 177
4. B. Angrist Amphetamine psychosis Clinical variations of the syndrome A.K. Cho D.S. Segal Amphetamine and Its Analogues 1994 Academic Press San Diego, CA 387 414
5. H.M. Arnold, J.A. Burk, E.M. Hodgson, M. Sarter, J.P. Bruno Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention Neuroscience 114 2002 451 460
6. D.L. Braff Information processing and attention dysfunctions in schizophrenia Schizophr Bull 19 1993 233 259
7. D.L. Braff, G.A. Light Preattentional and attentional cognitive deficits as targets for treating schizophrenia Psychopharmacology (Berl) 174 2004 75 85
8. S.A. Castner, M.S. al-Tikriti, R.M. Baldwin, J.P. Seibyl, R.B. Innis, P.S. Goldman-Rakic Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine Neuropsychopharmacology 22 2000 4 13
9. S.A. Castner, P.S. Goldman-Rakic Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates Biol Psychiatry 54 2003 105 110
10. J.M. Crook, E. Tomaskovic-Crook, D.L. Copolov, B. Dean Decreased muscarinic receptor binding in subjects with schizophrenia A study of the human hippocampal formation Biol Psychiatry 48 2000 381 388
11. J.M. Crook, E. Tomaskovic-Crook, D.L. Copolov, B. Dean Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia A study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment Am J Psychiatry 158 2001 918 925
12. J.L. Evenden, T.W. Robbins Dissociable effects of d-amphetamine, chlordiazepoxide and alpha-flupenthixol on choice and rate measures of reinforcement in the rat Psychopharmacology (Berl) 79 1983 180 186
13. J.L. Evenden, T.W. Robbins Increased response switching, perseveration and perseverative switching following d-amphetamine in the rat Psychopharmacology (Berl) 80 1983 67 73
14. P.W. Frey, J.A. Colliver Sensitivity and responsivity measures for discrimination learning Learn Motivation 4 1973 327 342
15. J.A. Gray Integrating schizophrenia Schizophr Bull 24 1998 249 266
16. A. Greenwald, R. Gonzalez, R. Harris, D. Guthrie Effects sizes and p-values What should be reported and what should be replicated Psychophysiology 33 1996 157 183
17. A.M. Himmelheber, M. Sarter, J.P. Bruno Increases in cortical acetylcholine release during sustained attention performance in rats Cogn Brain Res 9 2000 313 325
18. K.M. Hughes, L. Popi, D.L. Wolgin Experiential constraints on the development of tolerance to amphetamine hypophagia following sensitization of stereotypy Instrumental contingencies regulate the expression of sensitization Psychopharmacology (Berl) 140 1998 445 449
19. D.J. Jentsch Pre-clinical models of cognitive dysfunction in schizophrenia New avenues to addressing unmet needs Clin Neurosci Res 3 2003 303 313
20. E. Jolkkonen, R. Miettinen, M. Pikkarainen, A. Pitkanen Projections from the amygdaloid complex to the magnocellular cholinergic basal forebrain in rat Neuroscience 111 2002 133 149
21. S. Kapur Psychosis as a state of aberrant salience A framework linking biology, phenomenology, and pharmacology in schizophrenia Am J Psychiatry 160 2003 13 23
22. R.S. Keefe, M.C. Arnold, U.J. Bayen, P.D. Harvey Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis Psychol Med 29 1999 903 914
23. R.L. Kondrad, J.A. Burk Transient disruption of attentional performance following escalating amphetamine administration in rats Psychopharmacology (Berl) 2004
24. R. Kuczenski, D.S. Segal An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens J Neurosci 17 1997 4441 4447
25. M. Laruelle The role of endogenous sensitization in the pathophysiology of schizophrenia Implications from recent brain imaging studies Brain Res Rev 31 2000 371 384
26. M. Laruelle, A. Abi-Dargham, R. Gil, L. Kegeles, R. Innis Increased dopamine transmission in schizophrenia Relationship to illness phases Biol Psychiatry 46 1999 56 72
27. M. Laruelle, A. Abi-Dargham, C.H. van Dyck, R. Gil, C.D. D'Souza, J. Erdos Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc Natl Acad Sci U S A 93 1996 9235 9240
28. C.S. Li Impaired detection of visual motion in schizophrenia patients Prog Neuropsychopharmacol Biol Psychiatry 26 2002 929 934
29. J.A. Lieberman, B.B. Sheitman, B.J. Kinon Neurochemical sensitization in the pathophysiology of schizophrenia Deficits and dysfunction in neuronal regulation and plasticity Neuropsychopharmacology 17 1997 205 229
30. J. McGaughy, M.W. Decker, M. Sarter Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats Psychopharmacology (Berl) 144 1999 175 182
31. J. McGaughy, T. Kaiser, M. Sarter Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain Selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density Behav Neurosci 110 1996 247 265
32. J. McGaughy, M. Sarter Behavioral vigilance in rats Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands Psychopharmacology (Berl) 117 1995 340 357
33. A. McGhie, J. Chapman Disorders of attention and perception in early schizophrenia Br J Med Psychol 34 1961 103 117
34. G.J. Mogenson, L.W. Swanson, M. Wu Neural projections from nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area An anatomical and electrophysiological investigation in the rat J Neurosci 3 1983 189 202
35. H. Moore, J. Fadel, M. Sarter, J.P. Bruno Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release Neuroscience 88 1999 811 822
36. G.N. Neigh, H.M. Arnold, R.L. Rabenstein, M. Sarter, J.P. Bruno Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release Neuroscience 123 2004 635 645
37. G. Neigh-McCandless, B.A. Kravitz, M. Sarter, J.P. Bruno Stimulation of cortical acetylcholine release following blockade of ionotropic glutamate receptors in nucleus accumbens Eur J Neurosci 16 2002 1259 1266
38. C.L. Nelson, M. Sarter, J.P. Bruno Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release Psychopharmacology (Berl) 151 2000 406 415
39. T.J. Ornstein, J.L. Iddon, A.M. Baldacchino, B.J. Sahakian, M. London, B.J. Everitt, T.W. Robbins Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers Neuropsychopharmacology 23 2000 113 126
40. M.M. Ostrander, A. Badiani, H.E. Day, C.S. Norton, S.J. Watson, H. Akil, T.E. Robinson Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain Neuroscience 120 2003 551 571
41. P.E. Paulson, D.M. Camp, T.E. Robinson Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats Psychopharmacology (Berl) 103 1991 480 492
42. P.E. Paulson, T.E. Robinson Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum A microdialysis study in behaving rats Synapse 19 1995 56 65
43. G. Paxinos, C. Watson The Rat Brain in Stereotaxic Coordinates 4th ed. 1988 Academic Press San Diego, CA
44. T.E. Robinson, J.B. Becker Enduring changes in brain and behavior produced by chronic amphetamine administration A review and evaluation of animal models of amphetamine psychosis Brain Res Rev 396 1986 157 198
45. R.D. Rogers, B.J. Everitt, A. Baldacchino, A.J. Blackshaw, R. Swainson, K. Wynne Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers Evidence for monoaminergic mechanisms Neuropsychopharmacology 20 1999 322 339
46. H. Russig, A. Durrer, B.K. Yee, C.A. Murphy, J. Feldon The acquisition, retention and reversal of spatial learning in the Morris water maze task following withdrawal from an escalating dosage schedule of amphetamine in Wistar rats Neuroscience 119 2003 167 179
47. F. Sams-Dodd, J.D. Newman Effects of administration regime on the psychotomimetic properties of d-amphetamine in the squirrel monkey (Saimiri sciureus) Pharmacol Biochem Behav 56 1997 471 480
48. M. Sarter, M.E. Hasselmo, J.P. Bruno, B. Givens Unraveling the attentional functions of cortical cholinergic inputs Interactions between signal-driven and top-down cholinergic modulation of signal detection Brain Res Rev 48 2005 98 111
49. M. Sarter, C.L. Nelson, J.P. Bruno Cortical cholinergic transmission and cortical information processing following psychostimulant-sensitization Implications for models of schizophrenia Schizophr Bull 31 2005 1 22
50. M. Sato, C.C. Chen, K. Akiyama, S. Otsuki Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis Biol Psychiatry 18 1983 429 440
51. P. Seeman, T. Tallerico, F. Ko, C. Tenn, S. Kapur Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges Synapse 46 2002 235 239
52. D.S. Segal, D.S. Janowski Psychostimulant-induced behavioral effects Possible models of schizophrenia M.A. Lipton A. DiMascio K.F. Killam Psychopharmacology A Generation of Progress 1978 Raven Press New York 1113 1124
53. S.M. Strakowski, K.W. Sax, M.J. Setters, S.P. Stanton, P.E. Keck Jr Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis Implications for a sensitization model of psychosis in humans Biol Psychiatry 42 1997 749 755
54. J.A. Swets, A.B. Kristofferson Attention Annu Rev Psychol 21 1970 339 366
55. J.A. Swets, R.M. Pickett Evaluation of Diagnostic Systems 1982 Academic Press New York
56. R. Tandon, S.F. Taylor, J.R. DeQuardo, E. Eiser, M.D. Jibson, M. Goldman The cholinergic system in schizophrenia reconsidered Neuropsychopharmacology 22 1999 S189 S202
57. C.C. Tenn, P.J. Fletcher, S. Kapur Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia Schizophr Res 64 2003 103 114
58. J. Turchi, M. Sarter Antisense oligodeoxynucleotide-induced suppression of basal forebrain NMDA-NR1 subunits selectively impairs visual attentional performance in rats Eur J Neurosci 14 2001 103 117
59. E.T. Tzavara, F.P. Bymaster, R.J. Davis, M.R. Wade, K.W. Perry, J. Wess M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission Relevance to the pathophysiology and treatment of related CNS pathologies Faseb J 18 2004 1410 1412
60. J.M. Uslaner, C.S. Norton, S.J. Watson, H. Akil, T.E. Robinson Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus Interactions between dose, environment, and neuronal phenotype J Neurochem 85 2003 105 114
61. R.J. van den Bosch, R.P. Rombouts, M.J. van Asma What determines continuous performance task performance? Schizophr Bull 22 1996 643 651
62. M. Vasey, J. Thayer The continuing problem of false positives in repeated measures ANOVA in psychophysiology A multivariate solution Psychophysiology 24 1987 479 486
63. P.H. Venables Input dysfunction in schizophrenia B.A. Maher Progress in Experimental Personality Research 1964 Academic Press New York 1 47
64. D.L. Wolgin Contingent tolerance to amphetamine hypophagia New insights into the role of environmental context in the expression of stereotypy Neurosci Biobehav Rev 24 2000 279 294
65. D.L. Wolgin Effects of chronic amphetamine on the appetitive and consummatory phases of feeding Appetite 38 2002 221 223
66. L. Zaborszky The modular organization of brain systems. Basal forebrain: the last frontier Prog Brain Res 136 2002 359 372
67. L. Zaborszky, K. Pang, J. Somogyi, Z. Nadasdy, I. Kallo The basal forebrain corticopetal system revisited Ann N Y Acad Sci 877 1999 339 367
68. J.H. Zar Biostatistical Analysis 1974 Prentice Hall Englewood Cliffs, NJ